Analysis of Substrate Specificity and Kinetics of Cyclic Nucleotide Phosphodiesterases with N'-Methylanthraniloyl-Substituted Purine and Pyrimidine 3′,5′-Cyclic Nucleotides by Fluorescence Spectrometry

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Reinecke, Daniel ^a   Schwede, Frank ^b   Genieser, Hans Gottfried ^b   Seifert, Roland ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b BIOLOG Life Science Institute   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC NUCLEOTIDE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; N' METHYLANTHRANILOYL SUBSTITUTED PURINE 3',5' CYCLIC NUCLEOTIDE; N' METHYLANTHRANILOYL SUBSTITUTED PYRIMIDINE 3',5' CYCLIC NUCLEOTIDE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL LABELING; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME KINETICS; ENZYME SPECIFICITY; FLUORESCENCE ANALYSIS; NUCLEOTIDE METABOLISM; PROTEIN CLEAVAGE; SPECTROFLUOROMETRY;

KINETICS; NUCLEOTIDES, CYCLIC; PHOSPHORIC DIESTER HYDROLASES; SPECTROMETRY, FLUORESCENCE; SUBSTRATE SPECIFICITY;

EID: 84872294433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054158     Document Type: Article

References (49)

1. Kots AY, Martin E, Sharina IG, Murad F, (2009) A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases. Hand. Ep. Pharmacol 191: 1-14.
2. Rehmann H, Wittinghofer A, Bos JL, (2007) Capturing cyclic nucleotides in action: snapshots from crystallographic studies. Nat Rev Mol Cell Biol 8: 63-73.
3. Hofmann F, Bernhard D, Lukowski R, Weinmeister P, (2009) cGMP regulated protein kinases (cGK). Handb Exp Pharmacol 191: 137-162.
4. Dessauer CW, (2009) Adenylyl cyclase-A-kinase anchoring protein complexes: the next dimension in cAMP signaling. Mol Pharmacol 76: 935-941.
5. Cech SY, Ignarro LJ, (1977) Cytidine 3′,5′-monophosphate (cyclic CMP) formation in mammalian tissues. Science 198: 1063-1065.
6. Gaion RM, Krishna G, (1979) Cytidylate cyclase: the product isolated by the method of Cech and Ignarro is not cytidine 3′,5′-monophosphate. Biochem Biophys Res Commun 86: 105-111.
7. Newton RP, Salih SG, Salvage BJ, Kingston EE, (1984) Extraction, purification and identification of cytidine 3′,5′-cyclic monophosphate from rat tissues. Biochem J 221: 665-673.
8. Newton RP, Kingston EE, Hakeem NA, Salih SG, Beynon JH, et al. (1986) Extraction, purification, identification and metabolism of 3′,5′-cyclic UMP, 3′,5′-cyclic IMP and 3′,5′-cyclic dTMP from rat tissues. Biochem J 236: 431-439.
9. Helfman DM, Katoh N, Kuo JF, (1984) Purification and properties of cyclic CMP phosphodiesterase. Adv Cyclic Nucleotide Protein Phosphorylation Res 16: 403-416.
10. Newton RP, Bayliss MA, Khan JA, Bastani A, Wilkins AC, et al. (1999) Kinetic analysis of cyclic CMP-specific and multifunctional phosphodiesterases by quantitative positive-ion fast atom bombardment mass spectrometry. Rapid Commun Mass Spectrom 13: 574-584.
11. Klotz U, Stock K, (1971) Evidence for a cyclic nucleotide-phosphodiesterase with high specificity for cyclic uridine-3′,5′-monophosphate in rat adipose tissue. Naunyn-Schmiedebergs Arch Pharmacol 269: 117-120.
12. Anderson TR, (1982) Cyclic cytidine 3′,5′-monophosphate (cCMP) in cell regulation. Mol Cell Endocrinol 28: 373-385.
13. Ervens J, Seifert R, (1991) Differential modulation by N4,2′-O-dibutyryl cytidine 3′:5′-cyclic monophosphate of neutrophil activation. Biochem Biophys Res Commun 174: 258-267.
14. Bloch A, Dutschman G, Maue R, (1974) Cytidine 3′,5′-monophosphate (cyclic CMP). II. Initiation of leukemia L-1210 cell growth in vitro. Biochem Biophys Res Commun 59: 955-959.
15. Burhenne H, Beste KY, Spangler CM, Voigt U, Kaever V, et al. (2011) Determination of cytidine 3′,5′-cyclic monophosphate and uridine 3′,5′-cyclic monophosphate in mammalian cell systems and in human urine by high-performance liquid chromatography/mass spectrometry Naunyn-Schmiedeberǵs Arch Pharmacol 383 (Suppl.), P096.
16. Beste KY, Burhenne H, Kaever V, Stasch JP, Seifert R, (2011) Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1. Biochemistry 51: 194-204.
17. Beste KY, Seifert R, (2012) Do cCMP, cUMP, cTMP, cIMP and cXMP play a role as second messengers? Development of a hypothesis based on studies with soluble guanylyl cyclase α1β1. Biol Chem 2012 Oct 17. pii/j/bchm (just-accepted/hsz-2012-0282/hsz-2012-0282:): xml doi: 10.1515/hsz-2012-0282. [Epub ahead of print.
18. Beste K, Hinz C, Kaever V, Seifert R (2012) Regulation of intracellular cCMP and cUMP concentrations by bicarbonate. Naunyn-Schmiedebergs Arch Pharmacol 385 (Suppl 1), S10.
19. Wolter S, Golombek M, Seifert R, (2011) Differential activation of cAMP- and cGMP-dependent protein kinases by cyclic purine and pyrimidine nucleotides. Biochem. Biophys Res Commun 415: 563-566.
20. Hammerschmidt A, Chatterji B, Zeiser J, Schröder A, Genieser HG, et al. (2012) Binding of regulatory subunits of cyclic AMP-dependent protein kinase to cyclic CMP agarose. PLoS One 7: e39848.
21. Ding S, Bond AE, Lemière F, Tuytten R, Esmans EL, et al. (2008) Online immobilized metal affinity chromatography/mass spectrometric analysis of changes elicited by cCMP in the murine brain phosphoproteome. Rapid Commun Mass Spectrom 22: 4129-4138.
22. Zong X, Krause S, Chen CC, Krueger J, Gruner C, et al. (2012) Regulation of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel activity by cCMP. J Biol Chem 287: 26506-26512.
23. Desch M, Schinner E, Kees F, Hofmann F, Seifert R, et al. (2010) Cyclic cytidine 3′,5′-monophosphate (cCMP) signals via cGMP kinase I. FEBS Lett. 584: 3979-3984.
24. Göttle M, Dove S, Kees F, Schlossmann J, Geduhn J, et al. (2010) Cytidylyl and uridylyl cyclase activity of Bacillus anthracis edema factor and Bordetella pertussis CyaA. Biochemistry 49: 5494-5503.
25. Bender AT, Beavo JA, (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58: 488-520.
26. Francis SH, Corbin JD, Bischoff E, (2009) Cyclic GMP-hydrolyzing phosphodiesterases. Handb Exp Pharmacol 191: 367-408.
27. Conti M, Beavo J, (2007) Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76: 481-511.
28. Hardman JG, Sutherland EW, (1965) A cyclic 3′,5′-nucleotide phosphodiesterase from heart with specificity for uridine 3′,5′-phosphate. J Biol Chem 240: 3704-3705.
29. Reinecke D, Burhenne H, Sandner P, Kaever V, Seifert R, (2011) Human cyclic nucleotide phosphodiesterases possess a much broader substrate-specificity than previously appreciated. FEBS Lett 585: 3259-3262.
30. Ren J, Goss DJ, (1996) Synthesis of a fluorescent 7-methylguanosine analog and a fluorescence spectroscopic study of its reaction with wheatgerm cap binding proteins. Nucleic Acid Res 24: 3629-3634.
31. Rensland H, John J, Linke R, Simon I, Schlichting I, et al. (1995) Substrate and product structural requirements for binding of nucleotides to H-ras p21: the mechanism of discrimination between guanosine and adenosine nucleotides. Biochemistry 34: 593-599.
32. Mou TC, Gille A, Fancy DA, Seifert R, Sprang SR, (2005) Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2′(3′)-O-(N-methylanthraniloyl)-guanosine 5′-triphosphate. J Biol Chem 280: 7253-7261.
33. Taha HM, Schmidt J, Göttle M, Suryanarayana S, Shen Y, et al. (2009) Molecular analysis of the interaction of anthrax adenylyl cyclase toxin, edema factor, with 2′(3′)-O-(N-(methyl)anthraniloyl)-substituted purine and pyrimidine nucleotides. Mol Pharmacol 75: 693-703.
34. Göttle M, Dove S, Steindel P, Shen Y, Tang WJ, et al. (2007) Molecular analysis of the interaction of Bordetella pertussis adenylyl cyclase with fluorescent nucleotides. Mol Pharmacol 72: 526-535.
35. Geduhn J, Dove S, Shen Y, Tang WJ, König B, et al. (2011) Bis-halogen-anthraniloyl-substituted nucleoside 5′-triphosphates as potent and selective inhibitors of Bordetella pertussis adenylyl cyclase toxin. J Pharmacol Exp Ther 336: 104-15.
36. Sullivan SM, Mishra R, Neubig RR, Maddock JR, (2000) Analysis of guanine nucleotide binding and exchange kinetics of the Escherichia coli GTPase Era. J Bacteriol 182: 3460-3466.
37. Pinto C, Lushington GH, Richter M, Gille A, Geduhn J, et al. (2011) Structure-activity relationships fort he interactions of 2′- and 3′-O-(N-methyl)anthraniloyl-substituted purine and pyrimidine nucleotides with mammalian adenylyl cyclases. Biochem Pharmacol 82: 358-370.
38. Pisareva VP, Pisarev AV, Hellen CU, Rodnina MV, Pestova TV, (2006) Kinetic analysis of interaction of eukaryotic release factor 3 with guanine nucleotides. J Biol Chem 281: 40224-40235.
39. Sharma IM, Dhanaraman T, Mathew R, Chatterji D, (2012) Synthesis and characterization of a fluorescent analogue of cyclic di-GMP. Biochemistry 51: 5443-5453.
40. Hiratsuka T, (1982) New fluorescent analogs of cAMP and cGMP available as substrates for cyclic nucleotide phosphodiesterase. J Biol Chem 257: 13354-13358.
41. Johnson JD, Walters JD, Mills JS, (1987) A continuous fluorescence assay for cyclic nucleotide phosphodiesterase hydrolysis of cyclic GMP. Anal Biochem 162: 291-295.
42. Gopalakrishna R, Anderson WB, (1982) Ca2+-induced hydrophobic site on calmodulin: application for purification of calmodulin by phenyl-sepharose affinity chromatography. Biochem Biophys Res Commun 29: 830-836.
43. Hiratsuka T, (1983) New ribose-modified fluorescent analogs of adenine and guanine nucleotides available as substrates for various enzymes. Biochim Biophys Acta 742: 496-508.
44. Kincaid RL, Stith-Coleman IE, Vaughan M, (1985) Proteolytic activation of calmodulin-dependent cyclic nucleotide phosphodiesterase. J Biol Chem 260: 9009-9015.
45. Chaudhry PS, Casillas ER, (1988) Calmodulin-stimulated cyclic nucleotide phosphodiesterases in plasma membranes of bovine epididymal spermatozoa. Arch Biochem Biophys 262: 439-444.
46. Berridge MJ, Lipp P, Bootman MD, (2000) The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1: 11-12.
47. Sager G, (2004) Cyclic GMP transporters. Neurochem Int 45: 865-873.
48. Borgognone A, Pulcinelli FM (2012) Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport. Thromb. Haemost. 108 PMID: 23014861.
49. Wielinga PR, van der Heijden I, Reid G, Beijnen JH, Wijnholds J, et al. (2003) Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem 278: 17664-17671.